The sulfonylurea controversy: much ado about nothing or cause for concern?
D000251:Adenosine Triphosphatases / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D004562:Electrocardiography / Q000187:drug effects*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000401:mortality*; D015221:Potassium Channels / Q000187:drug effects; D013453:Sulfonylurea Compounds / Q000009:adverse effects*
D015221:Potassium Channels; D013453:Sulfonylurea Compounds; D000251:Adenosine Triphosphatases